CSF3 and thyroid gland disorder: Kurimoto et al. measured the changes of various cytokines before and after ICIs treatment and identified that an increase in IL-2 and a decrease in granulocyte colony-stimulating factor (G-CSF) appeared to be associated with thyroid immune-related adverse events (irAEs) [22].